Advances in male hormone substitution therapy (Q36221968)

12 August 2017

1 reference

title

Advances in male hormone substitution therapy (English)

1 reference

12 August 2017

3

Christina Wang

1 reference

12 August 2017

Ammar Qoubaitary

1

1 reference

PubMed ID

16086637

12 August 2017

Ronald S Swerdloff

series ordinal

2

1 reference

PubMed ID

16086637

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

1493-1506

1 reference

12 August 2017

9

1 reference

Molecular action of androgens

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Androgen receptor (AR) coregulators: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Molecular biology of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

The role of 5alpha-reduction in steroid hormone physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Estrogen signaling: a subtle balance between ER alpha and ER beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Estradiol in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Diagnosis of hypogonadism in the aging male

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Evaluation of assays available to measure free testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Testosterone replacement therapy: current trends and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Endocrine disorders in men infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Androgen therapy in AIDS wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Newer agents for hormonal contraception in the male

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Use of progestins in male contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Contraceptive efficacy of testosterone-induced azoospermia in normal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Contraceptive efficacy of a depot progestin and androgen combination in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Neuropsychological profiles of adults with Klinefelter syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Cognitive effects of short-term manipulation of serum sex steroids in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Testosterone supplementation improves spatial and verbal memory in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Testosterone influences spatial cognition in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Effects of androgen therapy on adipose tissue and metabolism in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Role of hormonal changes in the pathogenesis of osteoporosis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Effect of testosterone and estradiol in a man with aromatase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Testosterone treatment for men with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Androgens and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Androgens and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

The clinical implications of the Prostate Cancer Prevention Trial (PCPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Testosterone release from a subcutaneous, biodegradable microcapsule formulation (Viatrel) in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Oral testosterone in oil plus dutasteride in men: a pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Important effect of food on the bioavailability of oral testosterone undecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Which testosterone replacement therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Nonsteroidal selective androgen receptors modulators (SARMs): designer androgens with flexible structures provide clinical promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Bone Anabolic Effects of S-40503, a Novel Nonsteroidal Selective Androgen Receptor Modulator (SARM), in Rat Models of Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Targeting steroid hormone receptor pathways in the treatment of hormone dependent cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

A selective androgen receptor modulator for hormonal male contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Transdermal dihydrotestosterone treatment of 'andropause'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1493

10.1517/14656566.6.9.1493

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16086637